Bioline RX Ltd Sponsored ADR Financial Overview
Bioline RX Ltd Sponsored ADR's market cap is currently $13.11M. The company's EPS TTM is $0; its P/E ratio is -2.20; Bioline RX Ltd Sponsored ADR is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
